HIGHLIGHTS
- who: Linan Song from the Eli Lilly and Company, Windlesham, UK have published the research: A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics, in the Journal: (JOURNAL)
- what: In the present study, a digital ELISA was developed for measuring plasma Aβ1-42 with improved sensitivity using single molecule array (Simoa) technology with antibodies 3D6 and 21F12, directed at the N- and C-termini of Aβ1-42, respectively. The aims of this study were also to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.